Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.50 |
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.50 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.50 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.50 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | MGLL | Q99685 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5194603 | 0.97 | TRPV6 (0.48) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| Water SCHEMBL4437584 | 0.97 | TRPV6 (0.48) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| Acetic Acid SCHEMBL29130478 | 0.89 | ORAI1 (0.41) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| Sulfuric Acid SCHEMBL17580243 | 0.89 | TSHR (0.43) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| Fluorene SCHEMBL28174323 | 0.82 | KDM4E (0.42) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL28154506 | 0.80 | ALDH1A1 (0.52) | CA14CA1CA2ALDH1A1KMT2A | |
| Phenoxazine SCHEMBL8355596 | 0.78 | ALOX5 (0.55) | KMT2AMEN1TDP1 | |
| SCHEMBL1848691 | 0.78 | TRPV6 (0.63) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL15678691 | 0.77 | MGLL (0.52) | ENPP2CA4CA6CA5ACA7 | |
| SCHEMBL5665675 | 0.77 | CA1 (0.61) | ENPP2CA7CA14CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081295-A | Phenylboronic acid-based living material for strengthening biological manufacturing process and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12629060-B2 | Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system | BIOLINQ INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| CN-122037235-A | Hydrogel buffer pad and preparation method and application thereof | 浙江省农业科学院 | 2026-05-15 | — | — | CN | claimed |
| CN-122032659-A | Modified macroporous strong alkali anion resin and preparation method and application thereof | 中国科学院青海盐湖研究所 | 2026-05-15 | — | — | CN | claimed |
| CN-121574335-A | Photo-curing resin, high-toughness adhesive product and preparation method thereof | 万华化学集团股份有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4658168-A2 | METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM | Biolinq, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| US-20250281080-A1 | METHOD FOR IMPROVED SENSOR SENSITIVITY OF A MICRONEEDLE-BASED CONTINUOUS ANALYTE MONITORING SYSTEM | BIOLINQ INCORPORATED | 2025-09-11 | — | — | US | claimed |
| US-12336816-B2 | Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system | BIOLINQ INCORPORATED (US) | 2025-06-24 | — | — | US | claimed |
| CN-119034006-B | Injectable hydrogel and preparation method and application thereof | 武汉大学中南医院 | 2025-06-17 | — | — | CN | claimed |
| CN-120040375-A | Enzyme-activated base type aggregation-induced emission photosensitizer and preparation method and application thereof | 香港中文大学（深圳） | 2025-05-27 | — | — | CN | claimed |
| WO-1998045450-A1 | PURIFIED TELOMERASE | GERON CORPORATION (US) | 1998-10-15 | — | — | WO | claimed |
| EP-0828759-A1 | PROCESS OF HIGH PURITY ALBUMIN PRODUCTION | Delta Biotechnology Limited (GB) | 1998-03-18 | — | — | EP | claimed |
| WO-1997031947-A1 | HIGH PURITY ALBUMIN PRODUCTION PROCESS | DELTA BIOTECHNOLOGY LIMITED (GB) | 1997-09-04 | — | — | WO | claimed |
| WO-1996037515-A1 | PROCESS OF HIGH PURITY ALBUMIN PRODUCTION | DELTA BIOTECHNOLOGY LIMITED (GB) | 1996-11-28 | — | — | WO | claimed |
| US-5512246-A | Method and means for detecting polyhydroxyl compounds | Russell, Anthony P. (US) | 1996-04-30 | — | — | US | claimed |
| EP-0491863-A1 | METHOD AND MEANS FOR DETECTING POLYHYDROXYL COMPOUNDS. | RUSSELL ANTHONY P (US) | 1992-07-01 | — | — | EP | claimed |
| WO-1991004488-A1 | METHOD AND MEANS FOR DETECTING POLYHYDROXYL COMPOUNDS | RUSSELL ANTHONY P (US) | 1991-04-04 | — | — | WO | claimed |
| US-4861728-A | Immunoassay of glycosylated hemoglobin using a labeled boron reagent | BECTON, DICKINSON AND COMPANY (US) | 1989-08-29 | — | — | US | claimed |
| US-4562251-A | Agarose derivatives of amino phenyl boronic acid | AMICON CORPORATION (US) | 1985-12-31 | — | — | US | claimed |
| US-4269605-A | COMPLEXING WITH A DIHYDROXYBORYL BONDED TO A SUPPORT; QUANTITATIVE ANALYSIS OF GLYCOSYLATED HEMOGLOBIN; DIABETES | AMICON CORPORATION (US) | 1981-05-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629060-B2 | Method for improved sensor sensitivity of a microneedle-based continuous analyte monitoring system | SLC2A8, SLC2A9, SLC2A3 | TRPV6 3493/4885ORAI1 2492/4885ORAI2 2869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.